Assistance to Medical Device Clusters for Common Facilities (AMD-CF) Scheme - Ministry of Chemicals & Fertilizers | Current Affairs | Vision IAS

Upgrade to Premium Today

Start Now
MENU
Home
Quick Links

High-quality MCQs and Mains Answer Writing to sharpen skills and reinforce learning every day.

Watch explainer and thematic concept-building videos under initiatives like Deep Dive, Master Classes, etc., on important UPSC topics.

A short, intensive, and exam-focused programme, insights from the Economic Survey, Union Budget, and UPSC current affairs.

ESC

Assistance to Medical Device Clusters for Common Facilities (AMD-CF) Scheme

Updated: 17 Oct 2025
Ministry: Ministry of Chemicals & Fertilizers
Beneficiary: Miscellaneous

Overview

The AMD-CF Scheme (2023–24 to 2026–27), managed by SIDBI, promotes self-reliance in medical device manufacturing by funding common facilities and testing laboratories within medical device clusters.

Quick Facts

  • Purpose: Promotes self-reliance in manufacturing of medical devices.
  • Tenure: 2023-24 to 2026-27
  • Components: Assistance for Common Facilities and Assistance for Testing Facilities
  • Project Management Agency: SIDBI

Objectives 

  • Strengthen Medical Device clusters by providing financial assistance and to strengthen and establish more Testing Laboratories for Medical Devices.

Salient Features 

Two Components 

  • Assistance for Common Facilities: For Creating Common Infrastructure Facilities. 
    • Incentive
      • Limit of support will be 70% of the approved project cost or Rs. 20 cr., whichever is less.
      • For Himalayan and North East Region States, grant-in-aid would be Rs. 20 Crore per Cluster or 90% of the project cost, whichever is less.
    • Special Purpose Vehicle (SPV) to be formed by the Medical Devices manufacturing units in a cluster to execute the project.
      • There shall be a minimum of 5 Medical Device manufacturing units as members of SPV.
      • State Government can also promote a cluster.
    • Individual manufacturing unit cannot hold more than 40% in the SPV. Medical Devices enterprises shall hold at least 51% equity of the SPV.
  • Assistance for Testing Facilities: To strengthen availability of more Medical Device Testing Laboratories in order to boost manufacturing of quality medical devices.
    • Incentive
      • Limit of support will be 70% of the approved Testing Facilities project cost or Rs. 5 cr., whichever is less.
      • For Himalayan and North East Region States, grant-in-aid would be Rs. 5 Crore per Cluster or 90% of the project cost, whichever is less.
    • Any National or State level Government or Private institutions interested to establish or strengthen testing facilities for testing of Class A, B, C and D medical devices including in-vitro diagnostic medical devices under MDR, 2017 are eligible.
      • Such legal entity under the Indian law will open a separate account for the funds to be utilized for the projects assisted under the sub-scheme.
A diagram showing the National Medical Devices Policy 2023 divided into Vision and Strategy sections - Vision includes accelerated growth with patient-centric approach, emerging as global leader achieving 10-12% market share over 25 years, and growing the sector from $11 Bn to $50 Bn by 2030; Strategy includes Regulatory Streamlining, Enabling Infrastructure, Facilitating R&D and Innovation, Attracting Investments, Human Resources Development, and Brand Positioning and Awareness Creation.